By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A mail-in blood test accurately detects markers ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer ...

Finger-prick blood test accurately detects Alzheimer’s biomarkers, enabling at-home collection and broader research ...

A new blood test for Alzheimer’s disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can ...

Imagine a simple blood test that could reveal if you’re at risk for Alzheimer’s disease, years before symptoms become severe. A new study shows that this could be a reality. For those at risk, this ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...